A 78‑year‑old woman with primary or secondary adrenal insufficiency on prednisone 40 mg daily presents with random fern‑like skin lesions; how should these lesions be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of Skin Lesions in a Patient on Supraphysiologic Prednisone

Immediate Priority: Address Glucocorticoid Over-Replacement

This 78-year-old woman is receiving 40 mg prednisone daily—a dose that is 8-10 times higher than the recommended replacement range for adrenal insufficiency and represents severe iatrogenic glucocorticoid excess, not physiologic replacement therapy. 1, 2

The "random fern-like skin lesions" (likely referring to striae or other glucocorticoid-induced skin changes) are almost certainly manifestations of chronic glucocorticoid toxicity from this supraphysiologic dose. 1

Algorithmic Approach to Management

Step 1: Confirm the Diagnosis of Adrenal Insufficiency

  • Review the original diagnostic workup to verify that adrenal insufficiency was properly diagnosed with morning cortisol and ACTH measurements or cosyntropin stimulation testing 1, 2
  • If no prior diagnostic confirmation exists, do not attempt testing while the patient remains on prednisone—the exogenous steroid will suppress the HPA axis and yield false results 2, 3

Step 2: Immediately Reduce to Physiologic Replacement Dosing

The correct replacement dose for confirmed adrenal insufficiency is:

  • Prednisone 4-5 mg daily (taken as a single morning dose), OR 1
  • Hydrocortisone 15-25 mg daily in divided doses (typically 10 mg at 7:00 AM, 5 mg at 12:00 PM, and 2.5-5 mg at 4:00 PM) 1, 4

Prednisolone 4-5 mg daily should only be considered in select patients who experience marked fluctuations in energy or when hydrocortisone is not tolerated. 1

Step 3: Add Mineralocorticoid Replacement if Primary Adrenal Insufficiency

  • If the patient has primary adrenal insufficiency (autoimmune, adrenoleukodystrophy, tuberculosis, hemorrhage), add fludrocortisone 50-200 µg daily taken in the morning 1, 5
  • Advise unrestricted salt and salty food intake, avoiding potassium-containing salt substitutes 1, 5
  • Secondary adrenal insufficiency does not require mineralocorticoid replacement 5, 6

Step 4: Evaluate the Skin Lesions After Dose Correction

Signs of glucocorticoid over-replacement include:

  • Weight gain (particularly truncal and facial) 1, 4
  • Peripheral edema 1, 4
  • Insomnia 1, 4
  • Skin changes: striae, easy bruising, thin fragile skin, poor wound healing 1

After reducing to physiologic replacement doses, reassess the skin lesions in 2-4 weeks:

  • Many glucocorticoid-induced skin changes will improve or stabilize once excess exposure is eliminated 1, 4
  • If lesions persist or worsen despite appropriate dosing, consider dermatology referral for biopsy to exclude other etiologies 1

Step 5: Monitor for Signs of Under-Replacement

After dose reduction, watch for symptoms requiring dose adjustment:

  • Lethargy, nausea, poor appetite, weight loss, increased pigmentation (primary AI only) indicate under-replacement 1, 2, 4
  • Morning nausea can be relieved by taking the first dose earlier and returning to sleep 1, 2

Step 6: Essential Patient Education

All patients with adrenal insufficiency must receive:

  • Medical alert bracelet or necklace indicating adrenal insufficiency 1, 2
  • Steroid emergency card 1, 2
  • Injectable hydrocortisone 100 mg IM kit with self-injection training 1, 2, 6
  • Stress-dosing instructions: double or triple the dose during fever, infection, or minor illness 2, 4, 6
  • Immediate emergency care instructions: for vomiting, severe illness, or inability to take oral medications 2, 6, 7

Critical Pitfalls to Avoid

Never continue supraphysiologic glucocorticoid doses (>7.5 mg prednisone equivalent) for chronic adrenal insufficiency replacement—this causes iatrogenic Cushing's syndrome with serious complications including osteoporosis, diabetes, cardiovascular disease, and skin fragility. 1, 4, 6

Never abruptly discontinue glucocorticoids in confirmed adrenal insufficiency—this will precipitate life-threatening adrenal crisis. 1, 2, 6

Never delay treatment of suspected adrenal crisis for diagnostic procedures—if the patient develops hypotension, altered mental status, or severe vomiting, give hydrocortisone 100 mg IV immediately plus 0.9% saline infusion at 1 L/hour. 1, 2, 6

Drug Interactions Requiring Dose Adjustment

Medications that increase glucocorticoid requirements:

  • Anticonvulsants (phenytoin, carbamazepine, phenobarbital) 1, 4
  • Rifampin and other antituberculosis drugs 1, 4
  • Topiramate 1

Substances that decrease glucocorticoid requirements (avoid or reduce dose):

  • Grapefruit juice 1, 4
  • Licorice 1, 4

For primary adrenal insufficiency, avoid medications that interfere with fludrocortisone:

  • Diuretics, acetazolamide, NSAIDs, carbenoxolone 1, 5
  • Drospirenone-containing contraceptives may require fludrocortisone dose increase 1, 5

Follow-Up Monitoring

Annual review should include:

  • Assessment of weight, blood pressure (supine and standing), and presence of peripheral edema 1, 5
  • Serum electrolytes (sodium, potassium) 1
  • Screening for new autoimmune disorders (thyroid function, diabetes, celiac disease, pernicious anemia) 2, 6
  • Bone mineral density every 3-5 years to assess for glucocorticoid-induced osteoporosis 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Adrenal Insufficiency in Hypo-osmolar Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hydrocortisone Dose Titration in Adrenal Insufficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Hypoaldosteronism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adrenal insufficiency.

Lancet (London, England), 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.